Risk of pediatric AD is associated with childhood obesity and correlated to weight loss and gain.

Researchers from MIT, Brigham and Women's Hospital, and Harvard Medical School have engineered a novel treatment for alopecia areata...

Skin Spectrum Quarterly: The Journal of Ethnodermatology™ is a new open-access dermatology journal dedicated to advancing optimal...

Registration is open for the 10th annual Skin Spectrum Summit . The Summit is an educational congress of healthcare professionals...

Extending the dosing interval of guselkumab from eight weeks to sixteen weeks is non-inferior for treating psoriasis in super-responders.

New research has revealed that plastic surgery patients who use marijuana often have elevated nicotine levels, even when they deny using...

Recent research has found smoking cessation significantly reduced the risk of developing hidradenitis suppurativa (HS). The findings were...

Cendakimab is safe and efficacious in treating moderate-to-severe AD in adult patients.